HealthFollowingEmerging
Trending in Peru · Health · Last observed Jul 20, 2026
onp trending in Peru
Interest in ONP-002 has surged due to its Phase IIa clinical trials targeting mild traumatic brain injury and concussion treatment.
The subject, explained
What is driving the attention?
ONP-002, developed by Oragenics, is currently undergoing Phase IIa clinical trials to explore its efficacy in treating mild traumatic brain injuries and concussions. Recent news highlights the opening of a second clinical trial site and approvals from health research ethics committees, including in Australia, as well as the dosing of the first patient.
Reporting and context
Sources connected to this search
Clinical Trials Arena
Oragenics opens second site for ONP-002 Phase IIa trial - Clinical Trials ArenaOragenics opens second site for ONP-002 Phase IIa trial Clinical Trials Arena
West Orange Times Observer
ONP to host firefly self-guided hike - West Orange Times Observer
Continue exploring